Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co LtdfiledCriticalWakunaga Pharmaceutical Co Ltd
Priority to JP56059516ApriorityCriticalpatent/JPS57175125A/ja
Publication of JPS57175125ApublicationCriticalpatent/JPS57175125A/ja
Publication of JPH0138478B2publicationCriticalpatent/JPH0138478B2/ja
Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.
Lymphoblastoid cell lines capable of continuously and spontaneously producing interferon, process for preparing the same, and process for the human interferon production by the same